Stiolto Respimat Spray, Metered
Pricing Report NDC 0597-0155-61

Current NADAC: $115.80015 per GM · Effective Sep 23, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Stiolto Respimat (NDC 0597-0155-61) is $115.80015 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Boehringer Ingelheim Pharmaceuticals, Inc., this medication is distributed in a 1 CARTRIDGE in 1 CARTON / 60 SPRAY, METERED in 1 CARTRIDGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$115.80015
Per GM

Effective Date
Sep 23, 2026
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 CARTRIDGE in 1 CARTON / 60 SPRAY, METERED in 1 CARTRIDGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2015, the NADAC wholesale price for (NDC ) has moved within a range of $76.25260 to $116.11679 per GM. Over this 10 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$76.2526 - $116.1168
Market Volatility
52.28% Variance
Latest Trend
0.01%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $115.80015 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 19, 2026 $115.79129 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $115.82046 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $115.81415 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $115.84972 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Apr 22, 2026 $115.83495 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2026 $115.84603 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Feb 18, 2026 $115.85016 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 21, 2026 $115.86029 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 17, 2025 $115.85995 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $115.86230 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $115.87593 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026